Novartis AG (NVS)

Price$149.16

Value ScoreC

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)6.75%

Price vs S&P 500 (4W)4.14%

VGM Score54.03

Market Capitalization$211.48B

P/E Ratio (Annual)18.99x

Indicated Dividend Yield (Annual)3.19%

All Metrics

P/CF (Annual)13.87x

Book Value / Share (Quarterly)$20.18

P/TBV (Annual)15.67x

Indicated Dividend (Annual)$3.70

Revenue Growth (3Y)9.10%

Cash Flow / Share (Quarterly)$8.37

Payout Ratio (TTM)120.63%

Price vs S&P 500 (YTD)0.40%

Gross Margin (TTM)75.41%

Net Profit Margin (TTM)24.06%

EPS (TTM)$6.98

10-Day Avg Trading Volume3.12M

EPS Excl Extra (TTM)$6.98

Revenue Growth (5Y)2.45%

EPS (Annual)$7.15

Dividend / Share (Annual)$4.02

ROI (Annual)17.16%

Gross Margin (Annual)75.82%

Net Profit Margin (5Y Avg)30.08%

Cash / Share (Quarterly)$3.61

P/E Basic Excl Extra (TTM)19.62x

Revenue Growth QoQ (YoY)-0.54%

EPS Growth (5Y)15.26%

P/E Normalized (Annual)18.99x

ROA (Last FY)12.60%

Revenue Growth TTM (YoY)5.77%

EBITD / Share (TTM)$9.02

ROE (5Y Avg)27.29%

Operating Margin (TTM)30.37%

Cash Flow / Share (Annual)$7.94

P/B Ratio6.90x

P/B Ratio (Quarterly)8.02x

Net Income / Employee (Annual)$185,800

EV / Revenue (TTM)5.43x

Net Interest Coverage (TTM)15.76x

ROA (TTM)12.27%

EPS Growth QoQ (YoY)-9.60%

EV / EBITDA (TTM)17.47x

EPS Incl Extra (Annual)$7.15

Current Ratio (Annual)1.12x

Quick Ratio (Quarterly)0.65x

3-Month Avg Trading Volume3.11M

52-Week Price Return24.09%

EV / Free Cash Flow (Annual)20.04x

P/E Incl Extra (TTM)19.62x

Revenue / Employee (TTM)$747,400

Tangible BV / Share (Quarterly)$8.76

P/S Ratio (Annual)4.71x

Asset Turnover (Annual)0.51x

52-Week High$131.00

Operating Margin (5Y Avg)23.98%

EPS Excl Extra (Annual)$7.15

CapEx CAGR (5Y)8.57%

Tangible BV CAGR (5Y)-3.32%

26-Week Price Return14.68%

Quick Ratio (Annual)0.89x

13-Week Price Return-9.22%

Total Debt / Equity (Annual)0.77x

Current Ratio (Quarterly)0.85x

Enterprise Value$305.55B

Revenue / Share Growth (5Y)5.80%

Asset Turnover (TTM)0.51x

Book Value / Share Growth (5Y)-0.84%

Revenue / Employee (Annual)$748,400

Inventory Turnover (Annual)2.27x

Pretax Margin (Annual)29.03%

Cash / Share (Annual)$6.04

3-Month Return Std Dev21.28%

Gross Margin (5Y Avg)74.71%

Net Income / Employee (TTM)$179,800

EBITDA CAGR (5Y)11.82%

EBITDA Interim CAGR (5Y)11.78%

ROE (Last FY)30.31%

Net Interest Coverage (Annual)13.97x

EPS Basic Excl Extra (Annual)$7.15

P/FCF (TTM)16.64x

Receivables Turnover (TTM)6.26x

EV / Free Cash Flow (TTM)19.14x

Total Debt / Equity (Quarterly)1.22x

EPS Incl Extra (TTM)$6.98

Receivables Turnover (Annual)6.89x

ROI (TTM)17.05%

Dividend Growth Rate (5Y)5.38%

P/S Ratio (TTM)4.72x

Pretax Margin (5Y Avg)29.46%

Revenue / Share (Annual)$28.81

Tangible BV / Share (Annual)$8.71

Forward P/E16.50x

Free OCF CAGR (5Y)6.62%

Price vs S&P 500 (52W)-0.28%

P/E Ratio (TTM)19.62x

EPS Growth TTM (YoY)9.27%

Year-to-Date Return7.65%

5-Day Price Return3.58%

EPS Normalized (Annual)$7.15

ROA (5Y Avg)12.66%

Net Profit Margin (Annual)24.83%

Month-to-Date Return0.14%

Cash Flow / Share (TTM)$6.56

EBITD / Share (Annual)$9.13

EPS Growth (3Y)31.22%

Operating Margin (Annual)31.00%

LT Debt / Equity (Annual)0.61x

P/CF (TTM)13.85x

ROI (5Y Avg)17.13%

P/E Excl Extra (TTM)19.62x

LT Debt / Equity (Quarterly)0.97x

EPS Basic Excl Extra (TTM)$6.98

P/TBV (Quarterly)15.67x

Payout Ratio (Annual)55.91%

P/B Ratio (Annual)5.68x

Dividend / Share (TTM)$4.49

Inventory Turnover (TTM)2.28x

Pretax Margin (TTM)28.06%

Book Value / Share (Annual)$24.04

Price vs S&P 500 (13W)-17.47%

Net Margin Growth (5Y)8.94%

Dividend Yield (TTM)3.27%

Beta1.12x

P/FCF (Annual)17.42x

Revenue / Share (TTM)$29.36

ROE (TTM)31.67%

52-Week Low$91.20

vGradeC

gGradeC

mGradeC

vgmGradeC

Show chart for

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

3.53

3.59

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
NVSNovartis AG	C	C	C	$149.16
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	B	$34.19

About

Novartis is a global pharmaceutical company specializing in innovative drug development across oncology, immunology, neuroscience, and respiratory/cardiovascular/metabolic diseases. It operates both an innovative medicines segment and an established medicines business with off-patent franchises. The U.S. accounts for approximately one-third of revenue, providing geographic diversification.